Corient Ia LLC Astrazeneca PLC Transaction History
Corient Ia LLC
- $141 Billion
- Q1 2025
A detailed history of Corient Ia LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Corient Ia LLC holds 7,000 shares of AZN stock, worth $482,650. This represents 0.37% of its overall portfolio holdings.
Number of Shares
7,000Holding current value
$482,650% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,402Shares Held
504MCall Options Held
6.05MPut Options Held
4.05M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.94 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.8 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.46 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.16 Billion0.47% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.66 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...